Find out how bite-size content is being used to reach time-poor readers in an era of information overload in our summary of the ISMPP Annual Meeting preview.
Could medical publishing benefit from a more dynamic system, where open publications can be updated and engagement is sought across disciplines?
An increased reliance on virtual congresses and digital technologies during the pandemic may herald lasting changes, and opportunities, in medical communications.
Join ISMPP’s free webinar on COVID-19 and publication planning.
Find out more about how medical publication professionals make decisions about authorship order.
PLOS ONE now offers Registered Reports, shifting peer review focus from results to the quality of study design. Is this part of the future of open science?
Listen to patient partnership specialist Lauri Arnstein’s perspectives on the role of patients in medical publishing.
Find out about the events and activities that took place for this year’s Rare Disease Day.
Jackie Marchington gives her perspective on the Good Practice for Conference Abstracts and Presentations (GPCAP) recommendations.
Less than half of trials on clinicaltrials.gov meet the FDAAA results reporting deadline in a study from Ben Goldacre’s EBM DataLab at Oxford University
Call to action: help us to keep delivering freely-accessible, high quality news for medical publication professionals
The Publication Plan is now welcoming sponsorship, help us to keep delivering high quality, freely available new for medical publication professionals
We summarise the key changes to the ICMJE recommendations for authors and medical publication professionals.
Caroline Halford, Digital Publishing Manager at Springer Healthcare, gives her view on the value of enhanced features and an update on the evolution of digital publishing.
A new poll result published in the MAP newsletter explores the best approach for dealing with a non-responsive lead author.
Help and guidance for writing narrative reviews and Delphi consensus statements.
Following the revised guidance on Plan S, Bernd Pulverer questions whether cOAlition S is making the most of the opportunity to push for open science.